Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase

The increase in antibiotic resistance among Gram-positive bacteria underscores the urgent need to develop new antibiotics. New antibiotics should target actively growing susceptible bacteria that are resistant to clinically accepted antibiotics including bacteria that are not growing or are protecte...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vladimir Vimberg, Leona Zieglerova, Aninda Mazumdar, Zsolt Szűcs, Aniko Borbás, Pál Herczegh, Gabriela Balikova Novotna
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/17c1c0e3cb234f2b884059fda98a0fcd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:17c1c0e3cb234f2b884059fda98a0fcd
record_format dspace
spelling oai:doaj.org-article:17c1c0e3cb234f2b884059fda98a0fcd2021-11-25T18:40:00ZTwo Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase10.3390/ph141111821424-8247https://doaj.org/article/17c1c0e3cb234f2b884059fda98a0fcd2021-11-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1182https://doaj.org/toc/1424-8247The increase in antibiotic resistance among Gram-positive bacteria underscores the urgent need to develop new antibiotics. New antibiotics should target actively growing susceptible bacteria that are resistant to clinically accepted antibiotics including bacteria that are not growing or are protected in a biofilm environment. In this paper, we compare the in vitro activities of two new semisynthetic glycopeptide antibiotics, MA79 and ERJ390, with two clinically used glycopeptide antibiotics—vancomycin and teicoplanin. The new antibiotics effectively killed not only exponentially growing cells of <i>Staphylococcus aureus</i>, but also cells in the stationary growth phase and biofilm.Vladimir VimbergLeona ZieglerovaAninda MazumdarZsolt SzűcsAniko BorbásPál HerczeghGabriela Balikova NovotnaMDPI AGarticleantibiotic resistanceglycopeptide antibiotics<i>Staphylococcus aureus</i>teicoplanin pseudoaglyconMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1182, p 1182 (2021)
institution DOAJ
collection DOAJ
language EN
topic antibiotic resistance
glycopeptide antibiotics
<i>Staphylococcus aureus</i>
teicoplanin pseudoaglycon
Medicine
R
Pharmacy and materia medica
RS1-441
spellingShingle antibiotic resistance
glycopeptide antibiotics
<i>Staphylococcus aureus</i>
teicoplanin pseudoaglycon
Medicine
R
Pharmacy and materia medica
RS1-441
Vladimir Vimberg
Leona Zieglerova
Aninda Mazumdar
Zsolt Szűcs
Aniko Borbás
Pál Herczegh
Gabriela Balikova Novotna
Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase
description The increase in antibiotic resistance among Gram-positive bacteria underscores the urgent need to develop new antibiotics. New antibiotics should target actively growing susceptible bacteria that are resistant to clinically accepted antibiotics including bacteria that are not growing or are protected in a biofilm environment. In this paper, we compare the in vitro activities of two new semisynthetic glycopeptide antibiotics, MA79 and ERJ390, with two clinically used glycopeptide antibiotics—vancomycin and teicoplanin. The new antibiotics effectively killed not only exponentially growing cells of <i>Staphylococcus aureus</i>, but also cells in the stationary growth phase and biofilm.
format article
author Vladimir Vimberg
Leona Zieglerova
Aninda Mazumdar
Zsolt Szűcs
Aniko Borbás
Pál Herczegh
Gabriela Balikova Novotna
author_facet Vladimir Vimberg
Leona Zieglerova
Aninda Mazumdar
Zsolt Szűcs
Aniko Borbás
Pál Herczegh
Gabriela Balikova Novotna
author_sort Vladimir Vimberg
title Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase
title_short Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase
title_full Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase
title_fullStr Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase
title_full_unstemmed Two Novel Semisynthetic Lipoglycopeptides Active against <i>Staphylococcus aureus</i> Biofilms and Cells in Late Stationary Growth Phase
title_sort two novel semisynthetic lipoglycopeptides active against <i>staphylococcus aureus</i> biofilms and cells in late stationary growth phase
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/17c1c0e3cb234f2b884059fda98a0fcd
work_keys_str_mv AT vladimirvimberg twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase
AT leonazieglerova twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase
AT anindamazumdar twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase
AT zsoltszucs twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase
AT anikoborbas twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase
AT palherczegh twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase
AT gabrielabalikovanovotna twonovelsemisyntheticlipoglycopeptidesactiveagainstistaphylococcusaureusibiofilmsandcellsinlatestationarygrowthphase
_version_ 1718410818502000640